UPDATE : Monday, September 7, 2020
상단여백
Celltrion adds reason why Remsima can target US market by Constance Williams 2017-05-11 11:50
Investors focus on Moon-related shares by Nam Doo-hyun 2017-05-10 20:02
Industry groups ask Moon to expand policy support by Marian Chu 2017-05-10 17:30
Changes in healthcare policy expected under President Moon by Marian Chu 2017-05-10 15:53
FDA gives accelerated approval to bladder cancer drug by Constance Williams 2017-05-10 11:11
라인
Korea’s share remains small in multinational pharmaceuticals’ operation by Marian Chu and Nam Doo-hyun 2017-05-09 02:53
Act on ‘well-dying’ caught up in controversy by Song Soo-youn 2017-05-08 18:06
Druggists up in arms over increase of medicines sold at convenience stores by Constance Williams 2017-05-04 13:35
Can Jardiance threaten Forxiga's dominance in treating diabetes? by Park Gi-taek 2017-05-04 13:30
Dilemma of professional manager system: Yuhan, Samjin by Lee Hye-seon 2017-05-04 09:26
라인
‘Korean drug market to grow twice faster than GDP until 2021’ by Lee Hye-seon 2017-05-02 14:33
Did Park's confidante appoint health-welfare minister, too? by Song Soo-youn 2017-05-02 11:46
FDA okays first drug for Batten disease by Constance Williams 2017-04-28 15:49
Court orders surgeon of dead musician to pay ₩1.6 billion by Choi Gwang-seok 2017-04-28 15:01
JW Pharmaceutical worst of 10 major drugmakers for women to work in by Nam Doo-hyun 2017-04-28 12:07
라인
FDA approves 1st treatment for liver cancer in decade by Constance Williams 2017-04-28 11:25
WHO official identifies medical barriers in low-income countries by Constance Williams 2017-04-28 10:20
Novartis Korea slammed with $48.6-million penalty by Marian Chu 2017-04-27 18:16
Medical industry earned $761 million from 364,000 foreign patients last year by Marian Chu 2017-04-27 17:27
Boryung’s 1Q sales hit ₩99.8 billion by Lee Hye-seon 2017-04-27 14:59
여백
여백
여백
Back to Top